NfL and GFAP levels were significantly increased in FTLD and AD, compared to HC (p = 0.005 and p < 0.001, respectively), whilst p-Tau181 levels were significantly increased in AD patients compared to FTLD and HC (both p < 0.001) (see Fig. 1). The gene discussed is GFAP; the disease is Alzheimer disease.